Breast Cancer Clinical Trial
Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer
Summary
This pilot clinical trial studies stress reduction in improving quality of life in patients with recurrent gynecologic or breast cancer. Participating in a stress reduction program may help improve quality of life in patients with gynecologic or breast cancer.
Full Description
PRIMARY OBJECTIVES:
I. To refine the intervention. II. Test the acceptability, feasibility, and clinical appropriateness of the intervention.
III. To provide a preliminary test of its efficacy.
OUTLINE:
Patients participate in a multi-component intervention based on cognitive and behavioral principles comprising mindfulness-based stress reduction (MBSR), an intervention to promote hopefulness, and a problem solving approach which navigates around obstacles or generates alternatives when goals become blocked. Additional topics may be covered as indicated by clinical need and patients goals. Biobehavioral components include addressing social and disease-specific quality of life, and pain education. Intensive treatment sessions continue weekly for 16 weeks followed by 2 biweekly and 2 monthly maintenance sessions.
After completion of study treatment, patients are followed up at 28 weeks.
Eligibility Criteria
Inclusion Criteria:
Diagnosis of recurrent breast or gynecologic cancer (any site) with any disease-free interval; second primary cancers do not meet this criterion
English speaking
Able and willing to give informed consent
To be considered for the blood and saliva collection, women must fulfill the following secondary criteria:
Diagnosis of recurrent breast or ovarian cancer with any disease-free interval
Exclusion Criteria:
Residence > 70 miles from research site
Subnormal intellectual potential (diagnosis of mental retardation)
Progressive neurological or chronic, progressive, debilitating condition (e.g., dementia)
Non-ambulatory
Life expectancy less than 160 days, per the treating oncologist
Current suicide risk sufficient to preclude treatment on an outpatient basis
Chronic inflammatory or autoimmune disorder (e.g., rheumatoid arthritis, lupus)
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Columbus Ohio, 43210, United States
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.